First human tests begin for new antibody treatment
NCT ID NCT07248865
Summary
This is the first study testing CLYM116 in people. Researchers want to see if this experimental antibody is safe and how it behaves in the body. The study will enroll 48 healthy adults who will receive either the drug or a placebo. The main goal is to check for side effects and measure how long the drug stays in the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Brisbane
RECRUITINGBrisbane, 4006, Australia
Conditions
Explore the condition pages connected to this study.